1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Global Opportunity Assessment of RNA-based Therapeutics and Vaccines: Genetic Diseases Indication Segment to Harness Maximum Revenue Share by 2026 End

Global Opportunity Assessment of RNA-based Therapeutics and Vaccines: Genetic Diseases Indication Segment to Harness Maximum Revenue Share by 2026 End

  • August 2018
  • 177 pages
  • ID: 5503717
  • Format: PDF
  • By Persistence Market Research

Summary

Table of Contents

This report examines the ‘Global RNA-based Therapeutics and Vaccines Market for the period 2019–2026. The primary objective of the report is to offer updates and information related to market opportunities in the global RNA-based Therapeutics and Vaccines Market.

The RNA-based Therapeutics and Vaccines Market is Segmented as Follows:
RNA-based Therapeutics and Vaccines Market, by Product Type
RNA-based Therapeutics and Vaccines Market, by Indication
RNA-based Therapeutics and Vaccines Market, by Region
This report covers the global RNA-based Therapeutics and Vaccines Market performance in terms of revenue contribution from various segments.The report begins with an overview of the RNA-based Therapeutics and Vaccines Market and its definitions.

The market viewpoints section underlines macro-economic factors influencing the growth of the RNA-based Therapeutics and Vaccines Market along with detailing its opportunity analysis.

The global RNA-based Therapeutics and Vaccines Market is segmented based on product type, indication and region. On the basis of product type, the market has been segmented as RNA-based Therapeutics and RNA-based Vaccines (mRNA).

On the basis of indication, the market is segmented as Oncology, Immunology, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, genetic diseases & others.

A detailed analysis has been provided for each region in terms of market size, Y-o-Y growth rate, & absolute $ opportunity.The regional market dynamics provide the key growth driver, restraints, and trends pertaining to each region.

The forecast of the RNA-based Therapeutics and Vaccines Market by country, product type, indication are represented in the tabular form for each region. This section also helps to understand the opportunity of the RNA-based Therapeutics and Vaccines Market in major countries by each segment.

In the next section of the report, the ‘Competitive Landscape’ is included to provide report audiences with a dashboard view and to access the key differentiators among the competitor firms.This section is primarily designed to provide clients with an objective and detailed comparative assessment of product development and strategies of key providers specific to the market segments.

Detailed profiles of players in the RNA-based Therapeutics and Vaccines Market are also provided in the report, which highlights company description, product/segment overview, SWOT analysis, key developments related to market and strategic overview.

The next section of the report highlights the market outlook for 2019–2026 and sets the forecast within the context of the RNA-based Therapeutics and Vaccines Market by region.The key regions assessed in this report include North America, Latin America, Europe, Asia Pacific and MEA.

A detailed analysis has been provided for each region in terms of market size, Y-o-Y growth rate and absolute $ opportunity.

The above sections – by product type, indication– evaluate the growth prospects of the RNA-based Therapeutics and Vaccines Market for the period 2019–2026. We have considered 2017 as the base year and provided data for the forecast period.

The final section of report represents the global scenario for the RNA-based Therapeutics and Vaccines Market along with Y-o-Y growth and market forecast till 2026.This section also evaluates the global market opportunity over the forecast period and also the absolute dollar opportunity for each year.

This section will help to understand the overall market growth of the RNA-based Therapeutics and Vaccines Market and the opportunity analysis for each year over the forecast period.

Bottom-up approach is used to validate the total market size obtained.The forecast presented in the report provides total revenue of the RNA-based Therapeutics and Vaccines Market over 2019–2026.

While forecasting the market size, we have considered the impact of several factors such product approvals for RNA-based Therapeutics and Vaccines Market, R&D investment by major players, pipeline analysis, penetration of products in different distribution channel, etc.However, quantifying the market across the aforementioned segments and regions is more a matter of quantifying expectations and identifying opportunities rather than rationalizing them after the forecast has been completed.

In addition, we have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the global market.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
15% Off

($4900)

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Herpes Zoster (Shingles) - Pipeline Review, H2 2019

Herpes Zoster (Shingles) - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

Herpes Zoster (Shingles) - Pipeline Review, H2 2019SummaryThe latest Pharmaceutical and Healthcare disease pipeline guide Herpes Zoster - Pipeline Review, H2 2019, provides an overview of the Herpes Zoste ...

Prescription Drugs Markets in China

Prescription Drugs Markets in China

  • $ 4000
  • September 2019

China’s demand for Prescription Drugs has grown at a fast pace in the past decade.In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth ...

China Human Vaccine Industry Report, 2019-2025

China Human Vaccine Industry Report, 2019-2025

  • $ 3000
  • August 2019

China has been the world’s biggest producer and consumer of human vaccines over four decades of planned vaccination, a program that has reduced incidence of multiple vaccine-targeted infectious diseases ...

Tetanus - Pipeline Review, H2 2019 $ 2000 November 2019


ref:plp2018

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on